WHO Immunization Implementation Guide
0.2.0 - ci-build

WHO Immunization Implementation Guide, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations/tree/main and changes regularly. See the Directory of published versions
Built from commit 31220c5a.

ConceptMap: ConceptMap to and from IMMZ.D DataElements

Official URL: http://smart.who.int/immunizations/ConceptMap/IMMZ.D.ConceptMap Version: 0.2.0
Active as of 2025-01-10 Computable Name: IMMZ_D_ConceptMap

Mapping to and from IMMZ.D Data Dictionary to other codesystems.

This mapping does not specify any particular context of use.


Group 1 Mapping from IMMZ.D CodeSystem for Data Elements to EventStatus

Source CodeRelationshipTarget Code
DE2 (Completed)is equivalent tocompleted
DE3 (Entered in error)is equivalent toentered-in-error
DE4 (Not done)is equivalent tonot-done

Group 2 Mapping from EventStatus to IMMZ.D CodeSystem for Data Elements

Source CodeRelationshipTarget Code
completedis equivalent toDE2 (Completed)
entered-in-erroris equivalent toDE3 (Entered in error)
not-doneis equivalent toDE4 (Not done)

Group 3 Mapping from IMMZ.D CodeSystem for Data Elements to AdverseEventOutcome

Source CodeRelationshipTarget Code
DE116 (Died)is equivalent tofatal
DE117 (Recovered)is equivalent toresolved
DE118 (Recovered with sequelae)is equivalent toresolvedWithSequelae
DE119 (Recovering)is equivalent torecovering
DE120 (Not recovered)is equivalent toongoing
DE121 (Unknown)is equivalent tounknown

Group 4 Mapping from AdverseEventOutcome to IMMZ.D CodeSystem for Data Elements

Source CodeRelationshipTarget Code
fatalis equivalent toDE116 (Died)
resolvedis equivalent toDE117 (Recovered)
resolvedWithSequelaeis equivalent toDE118 (Recovered with sequelae)
recoveringis equivalent toDE119 (Recovering)
ongoingis equivalent toDE120 (Not recovered)
unknownis equivalent toDE121 (Unknown)

Group 5 Mapping from IMMZ.D CodeSystem for Data Elements to International Classification of Diseases, 11th Revision Mortality and Morbidity Statistics (MMS)

Source CodeRelationshipTarget CodeComment
DE158 (Due)is related toQC06 (Underimmunization status)
DE159 (Contraindicated)is related toQC04.Z (Immunization not carried out for unspecified reason)
DE162 (Currently pregnant)is equivalent toQA41 (Pregnant state)
DE163 (Immunocompromised)is narrower than4B4Z (Diseases of the immune system, unspecified)
DE200 (Severely immunocompromised)is narrower than4B4Z (Diseases of the immune system, unspecified)
DE164 (Exposed to immunosuppressive treatment)is narrower thanPH48 (Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances)
DE165 (Severely immunosuppressed)is related to4B4Z (Diseases of the immune system, unspecified)
DE187 (Immunodeficiency syndromes)is narrower than4B4Z (Diseases of the immune system, unspecified)
DE166 (History of anaphylactic reactions)is equivalent toQC44.0 (Personal history of anaphylaxis)
DE167 (Severe allergic reactions)is related toQC44.2 (Personal history of allergy to drugs, medicaments or biological substances)
DE168 (Symptomatic HIV infection)is equivalent to1C62.1 (HIV disease clinical stage 2 without mention of tuberculosis or malaria)
DE170 (Receiving blood products)is broader thanQB98 (Blood transfusion without reported diagnosis)Per the Immunizations DAK
DE188 (Severe acute illness)is related toMG25 (Feeling ill)
DE190 (TB disease)is narrower than1B1Z (Tuberculosis, unspecified)
DE191 (Breastfeeding)is narrower thanQA48.1 (Care or examination of lactating mother)
DE192 (Spina bifida)is equivalent toLA02 (Spina bifida)
DE193 (Bladder exstrophy)is equivalent toLB31.3 (Exstrophy of urinary bladder)
DE194 (Acute gastroenteritis)is narrower than1A40.Z (Infectious gastroenteritis or colitis without specification of infectious agent)
DE195 (Moderate to severe fever)is narrower thanMG26 (Fever of other or unknown origin)
DE86 (Client education and counselling on immunization)is equivalent toQA1Y (Contact with health services for other specified counselling)
DE87 (Counselling on functions of the immunological system)is narrower thanQA1Y (Contact with health services for other specified counselling)
DE88 (Advising about functions of the immunological system)is narrower thanQA1Y (Contact with health services for other specified counselling)
DE89 (Education to influence immunization behaviours)is narrower thanQA1Y (Contact with health services for other specified counselling)
DE90 (Advising about immunization behaviours)is narrower thanQA1Y (Contact with health services for other specified counselling)
DE91 (Awareness raising to influence immunization behaviours)is narrower thanQA1Y (Contact with health services for other specified counselling)
DE5 (Reason vaccine was not administered)is related toQC04 (Immunization not carried out)
DE6 (Immunity)is narrower thanQC04.Y (Immunization not carried out for other reasons)
DE7 (Medical precaution)is narrower thanQC04.Y (Immunization not carried out for other reasons)
DE8 (Product out of stock)is narrower thanQC04.7 (Immunization not carried out due to lack of availability)
DE9 (Client objection)is equivalent toQC04.5 (Immunization not carried out because of patient refusal)
DE10 (Caregiver refusal)is equivalent toQC04.6 (Immunization not carried out because of caregiver refusal)
DE11 (Unspecified reason)is equivalent toQC04.Z (Immunization not carried out for unspecified reason)
DE12 (Client allergy to vaccine or component)is equivalent toQC04.4 (Immunization not carried out because of patient allergy to vaccine or component)
DE13 (Immunocompromised)is equivalent toQC04.3 (Immunization not carried out because of immune-compromised state of patient)
DE14 (Chronic illness or condition)is equivalent toQC04.2 (Immunization not carried out because of chronic illness or condition of patient)
DE15 (Acute illness)is equivalent toQC04.1 (Immunization not carried out because of acute illness)
DE16 (Had the disease)is equivalent toQC04.0 (Immunization not carried out due to patient having had the disease)
DE17 (Immunization not carried out for other reasons)is equivalent toQC04.Y (Immunization not carried out for other reasons)
DE127 (Typhoid)is equivalent to1A07 (Typhoid fever)
DE128 (Influenza)is related to1E32 (Influenza, virus not identified)
DE129 (Measles)is equivalent to1F03 (Measles)
DE133 (Pertussis)is equivalent to1C12 (Whooping cough)
DE135 (Mumps)is equivalent to1D80 (Mumps)
DE136 (Varicella)is equivalent to1E90 (Varicella)
DE137 (Viral hepatitis A)is broader than1E50.0 (Acute hepatitis A)Per the Immunizations DAK
DE139 (Tuberculosis)is narrower than1B1Z (Tuberculosis, unspecified)
DE140 (Viral hepatitis B)is broader than1E50.1 (Acute hepatitis B)Per the Immunizations DAK
DE141 (Haemophilus influenzae type b)is equivalent toXN0FG (Haemophilus influenzae type B)
DE142 (Tetanus)is equivalent to1C13 (Tetanus)
DE143 (Rotavirus)is equivalent toXN6N7 (Rotavirus)
DE144 (Human papillomavirus)is equivalent toXN8JY (Human papillomavirus)
DE175 (Japanese encephalitis)is equivalent to1C85 (Japanese encephalitis)
DE146 (Poliomyelitis)is broader than1C81 (Acute poliomyelitis)Per the Immunizations DAK
DE176 (Diphtheria)is equivalent to1C17 (Diphtheria)
DE177 (Pneumococcal disease)is equivalent toCA40.07 (Pneumonia due to Streptococcus pneumoniae)
DE178 (Rubella)is equivalent to1F02 (Rubella)
DE179 (Dengue)is broader than1D2Z (Dengue, unspecified)Per the Immunizations DAK
DE180 (Rabies)is equivalent to1C82 (Rabies)
DE181 (Meningococcal)is equivalent to1C1C (Meningococcal disease)
DE182 (Cholera)is equivalent to1A00 (Cholera)
DE183 (Tick-borne encephalitis)is narrower than1C80 (Viral encephalitis, not elsewhere classified)
DE184 (Yellow fever)is equivalent to1D47 (Yellow fever)
DE148 (COVID-19)is equivalent toRA01 (COVID-19)
DE92 (Reaction reported)is related toPK81.7 (Injection or infusion for therapeutic or diagnostic purposes associated with injury or harm in therapeutic use)
DE95 (Reaction manifestation)is narrower thanNE80.3 (Other serum reactions)
DE96 (Severe local reaction)is broader thanEH77 (Localised adverse cutaneous reactions to administration of drug)Per the Immunizations DAK
DE98 (Seizures)is broader than8A63.Y (Seizure due to other acute cause)Per the Immunizations DAK
DE99 (Abscess)is broader than1B75.3 (Pyogenic abscess of the skin)Per the Immunizations DAK
DE100 (Sepsis)is broader than1G40 (Sepsis without septic shock)Per the Immunizations DAK
DE101 (Encephalopathy)is broader than8E47 (Encephalopathy, not elsewhere classified)Per the Immunizations DAK
DE102 (Toxic shock syndrome)is equivalent to1C45 (Toxic shock syndrome)
DE103 (Anaphylaxis)is equivalent to4A84 (Anaphylaxis)
DE104 (Fever)is broader thanMG26 (Fever of other or unknown origin)Per the Immunizations DAK
DE105 (Other)is broader thanNE80.Y (Other specified injury or harm arising following infusion, transfusion or therapeutic injection, not elsewhere classified)Per the Immunizations DAK
DE109 (Life threatening)is related toXS2R (Profound)
DE110 (Disability)is broader thanQF10 (Limited function or disability of body organ or system)Per the Immunizations DAK
DE205 (HIV-positive)is broader than1C62.Z (Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified)Per the Immunizations DAK
DE206 (HIV-negative)is related toQA02.Y (Medical observation or evaluation for other suspected diseases or conditions, ruled out)
DE208 (Preterm birth)is equivalent toKA21.4 (Preterm newborn)
DE209 (Immunocompromised)is narrower than4B4Z (Diseases of the immune system, unspecified)
DE245 (TST)is equivalent toXM0EK6 (Tuberculin, purified protein derivative (PPD))
DE247 (Positive)is related to1B1Z (Tuberculosis, unspecified)
DE248 (Negative)is related toQA02.0 (Observation for suspected tuberculosis, ruled out)
DE211 (Birth weight in grams)is related toKA21 (Disorders of newborn related to short gestation or low birth weight, not elsewhere classified)
DE212 (Type of poliovirus dose)is related toXM0N50 (Poliomyelitis vaccines)
DE213 (IPV)is equivalent toXM5V19 (Poliomyelitis, trivalent, inactivated, whole virus)
DE214 (bOPV)is equivalent toXM79H3 (Poliomyelitis oral, bivalent, live attenuated)
DE217 (Inactivated Vero cell-derived vaccine)is narrower thanXM0LB5 (Encephalitis, Japanese, inactivated, whole virus)
DE218 (Live attenuated vaccine)is equivalent toXM47S0 (Encephalitis, Japanese, live attenuated)
DE221 (FSME-Immun)is narrower thanXM8MP6 (Encephalitis, tick borne, inactivated, whole virus)
DE222 (Encepur)is narrower thanXM8MP6 (Encephalitis, tick borne, inactivated, whole virus)
DE223 (TBE-Moscow)is narrower thanXM8MP6 (Encephalitis, tick borne, inactivated, whole virus)
DE224 (EnceVir)is narrower thanXM8MP6 (Encephalitis, tick borne, inactivated, whole virus)
DE226 (Typbar-TCV)is narrower thanXM8BU8 (Typhoid vaccines)
DE227 (ViPS)is narrower thanXM3SF6 (Typhoid, purified polysaccharide antigen vaccines)
DE228 (Ty21a)is narrower thanXM33K4 (Typhoid, oral, live attenuated vaccines)
DE230 (WC vaccine)is equivalent toXM3Z26 (Cholera, inactivated, whole cell vaccines)
DE231 (WC-rBS vaccine)is narrower thanXM29K4 (Cholera vaccines)
DE233 (MenA conjugate vaccine (5µg))is equivalent toXM2280 (Meningococcus A, purified polysaccharides antigen conjugated vaccines)
DE234 (Monovalent MenC conjugate)is equivalent toXM18Y8 (Meningococcus C, purified polysaccharides antigen conjugated vaccines)
DE235 (Quadrivalent conjugate)is equivalent toXM2EH7 (Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated vaccines)
DE252 (Polysaccharide vaccine)is broader thanXM92B2 (Meningococcal monovalent purified polysaccharides antigen vaccines)Per the Immunizations DAK
DE238 (Live attenuated hepatitis A vaccine)is narrower thanXM6LL6 (Hepatitis vaccines)
DE239 (Inactivated hepatitis A vaccine)is equivalent toXM2A12 (Hepatitis A, inactivated, whole virus)
DE255 (Hepatitis B monovalent vaccine)is related toXM9V38 (Hepatitis B, purified antigen)

Group 6 Mapping from International Classification of Diseases, 11th Revision Mortality and Morbidity Statistics (MMS) to IMMZ.D CodeSystem for Data Elements

Source CodeRelationshipTarget CodeComment
QC06 (Underimmunization status)is related toDE158 (Due)
QC04.Z (Immunization not carried out for unspecified reason)is related toDE159 (Contraindicated)
QA41 (Pregnant state)is equivalent toDE162 (Currently pregnant)
4B4Z (Diseases of the immune system, unspecified)is broader thanDE163 (Immunocompromised)Per the Immunizations DAK
4B4Z (Diseases of the immune system, unspecified)is broader thanDE200 (Severely immunocompromised)Per the Immunizations DAK
PH48 (Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances)is broader thanDE164 (Exposed to immunosuppressive treatment)Per the Immunizations DAK
4B4Z (Diseases of the immune system, unspecified)is related toDE165 (Severely immunosuppressed)
4B4Z (Diseases of the immune system, unspecified)is broader thanDE187 (Immunodeficiency syndromes)Per the Immunizations DAK
QC44.0 (Personal history of anaphylaxis)is equivalent toDE166 (History of anaphylactic reactions)
QC44.2 (Personal history of allergy to drugs, medicaments or biological substances)is related toDE167 (Severe allergic reactions)
1C62.1 (HIV disease clinical stage 2 without mention of tuberculosis or malaria)is equivalent toDE168 (Symptomatic HIV infection)
QB98 (Blood transfusion without reported diagnosis)is narrower thanDE170 (Receiving blood products)
MG25 (Feeling ill)is related toDE188 (Severe acute illness)
1B1Z (Tuberculosis, unspecified)is broader thanDE190 (TB disease)Per the Immunizations DAK
QA48.1 (Care or examination of lactating mother)is broader thanDE191 (Breastfeeding)Per the Immunizations DAK
LA02 (Spina bifida)is equivalent toDE192 (Spina bifida)
LB31.3 (Exstrophy of urinary bladder)is equivalent toDE193 (Bladder exstrophy)
1A40.Z (Infectious gastroenteritis or colitis without specification of infectious agent)is broader thanDE194 (Acute gastroenteritis)Per the Immunizations DAK
MG26 (Fever of other or unknown origin)is broader thanDE195 (Moderate to severe fever)Per the Immunizations DAK
QA1Y (Contact with health services for other specified counselling)is equivalent toDE86 (Client education and counselling on immunization)
QA1Y (Contact with health services for other specified counselling)is broader thanDE87 (Counselling on functions of the immunological system)Per the Immunizations DAK
QA1Y (Contact with health services for other specified counselling)is broader thanDE88 (Advising about functions of the immunological system)Per the Immunizations DAK
QA1Y (Contact with health services for other specified counselling)is broader thanDE89 (Education to influence immunization behaviours)Per the Immunizations DAK
QA1Y (Contact with health services for other specified counselling)is broader thanDE90 (Advising about immunization behaviours)Per the Immunizations DAK
QA1Y (Contact with health services for other specified counselling)is broader thanDE91 (Awareness raising to influence immunization behaviours)Per the Immunizations DAK
QC04 (Immunization not carried out)is related toDE5 (Reason vaccine was not administered)
QC04.Y (Immunization not carried out for other reasons)is broader thanDE6 (Immunity)Per the Immunizations DAK
QC04.Y (Immunization not carried out for other reasons)is broader thanDE7 (Medical precaution)Per the Immunizations DAK
QC04.7 (Immunization not carried out due to lack of availability)is broader thanDE8 (Product out of stock)Per the Immunizations DAK
QC04.5 (Immunization not carried out because of patient refusal)is equivalent toDE9 (Client objection)
QC04.6 (Immunization not carried out because of caregiver refusal)is equivalent toDE10 (Caregiver refusal)
QC04.Z (Immunization not carried out for unspecified reason)is equivalent toDE11 (Unspecified reason)
QC04.4 (Immunization not carried out because of patient allergy to vaccine or component)is equivalent toDE12 (Client allergy to vaccine or component)
QC04.3 (Immunization not carried out because of immune-compromised state of patient)is equivalent toDE13 (Immunocompromised)
QC04.2 (Immunization not carried out because of chronic illness or condition of patient)is equivalent toDE14 (Chronic illness or condition)
QC04.1 (Immunization not carried out because of acute illness)is equivalent toDE15 (Acute illness)
QC04.0 (Immunization not carried out due to patient having had the disease)is equivalent toDE16 (Had the disease)
QC04.Y (Immunization not carried out for other reasons)is equivalent toDE17 (Immunization not carried out for other reasons)
1A07 (Typhoid fever)is equivalent toDE127 (Typhoid)
1E32 (Influenza, virus not identified)is related toDE128 (Influenza)
1F03 (Measles)is equivalent toDE129 (Measles)
1C12 (Whooping cough)is equivalent toDE133 (Pertussis)
1D80 (Mumps)is equivalent toDE135 (Mumps)
1E90 (Varicella)is equivalent toDE136 (Varicella)
1E50.0 (Acute hepatitis A)is narrower thanDE137 (Viral hepatitis A)
1B1Z (Tuberculosis, unspecified)is broader thanDE139 (Tuberculosis)Per the Immunizations DAK
1E50.1 (Acute hepatitis B)is narrower thanDE140 (Viral hepatitis B)
XN0FG (Haemophilus influenzae type B)is equivalent toDE141 (Haemophilus influenzae type b)
1C13 (Tetanus)is equivalent toDE142 (Tetanus)
XN6N7 (Rotavirus)is equivalent toDE143 (Rotavirus)
XN8JY (Human papillomavirus)is equivalent toDE144 (Human papillomavirus)
1C85 (Japanese encephalitis)is equivalent toDE175 (Japanese encephalitis)
1C81 (Acute poliomyelitis)is narrower thanDE146 (Poliomyelitis)
1C17 (Diphtheria)is equivalent toDE176 (Diphtheria)
CA40.07 (Pneumonia due to Streptococcus pneumoniae)is equivalent toDE177 (Pneumococcal disease)
1F02 (Rubella)is equivalent toDE178 (Rubella)
1D2Z (Dengue, unspecified)is narrower thanDE179 (Dengue)
1C82 (Rabies)is equivalent toDE180 (Rabies)
1C1C (Meningococcal disease)is equivalent toDE181 (Meningococcal)
1A00 (Cholera)is equivalent toDE182 (Cholera)
1C80 (Viral encephalitis, not elsewhere classified)is broader thanDE183 (Tick-borne encephalitis)Per the Immunizations DAK
1D47 (Yellow fever)is equivalent toDE184 (Yellow fever)
RA01 (COVID-19)is equivalent toDE148 (COVID-19)
PK81.7 (Injection or infusion for therapeutic or diagnostic purposes associated with injury or harm in therapeutic use)is related toDE92 (Reaction reported)
NE80.3 (Other serum reactions)is broader thanDE95 (Reaction manifestation)Per the Immunizations DAK
EH77 (Localised adverse cutaneous reactions to administration of drug)is narrower thanDE96 (Severe local reaction)
8A63.Y (Seizure due to other acute cause)is narrower thanDE98 (Seizures)
1B75.3 (Pyogenic abscess of the skin)is narrower thanDE99 (Abscess)
1G40 (Sepsis without septic shock)is narrower thanDE100 (Sepsis)
8E47 (Encephalopathy, not elsewhere classified)is narrower thanDE101 (Encephalopathy)
1C45 (Toxic shock syndrome)is equivalent toDE102 (Toxic shock syndrome)
4A84 (Anaphylaxis)is equivalent toDE103 (Anaphylaxis)
MG26 (Fever of other or unknown origin)is narrower thanDE104 (Fever)
NE80.Y (Other specified injury or harm arising following infusion, transfusion or therapeutic injection, not elsewhere classified)is narrower thanDE105 (Other)
XS2R (Profound)is related toDE109 (Life threatening)
QF10 (Limited function or disability of body organ or system)is narrower thanDE110 (Disability)
1C62.Z (Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified)is narrower thanDE205 (HIV-positive)
QA02.Y (Medical observation or evaluation for other suspected diseases or conditions, ruled out)is related toDE206 (HIV-negative)
KA21.4 (Preterm newborn)is equivalent toDE208 (Preterm birth)
4B4Z (Diseases of the immune system, unspecified)is broader thanDE209 (Immunocompromised)Per the Immunizations DAK
XM0EK6 (Tuberculin, purified protein derivative (PPD))is equivalent toDE245 (TST)
1B1Z (Tuberculosis, unspecified)is related toDE247 (Positive)
QA02.0 (Observation for suspected tuberculosis, ruled out)is related toDE248 (Negative)
KA21 (Disorders of newborn related to short gestation or low birth weight, not elsewhere classified)is related toDE211 (Birth weight in grams)
XM0N50 (Poliomyelitis vaccines)is related toDE212 (Type of poliovirus dose)
XM5V19 (Poliomyelitis, trivalent, inactivated, whole virus)is equivalent toDE213 (IPV)
XM79H3 (Poliomyelitis oral, bivalent, live attenuated)is equivalent toDE214 (bOPV)
XM0LB5 (Encephalitis, Japanese, inactivated, whole virus)is broader thanDE217 (Inactivated Vero cell-derived vaccine)Per the Immunizations DAK
XM47S0 (Encephalitis, Japanese, live attenuated)is equivalent toDE218 (Live attenuated vaccine)
XM8MP6 (Encephalitis, tick borne, inactivated, whole virus)is broader thanDE221 (FSME-Immun)Per the Immunizations DAK
XM8MP6 (Encephalitis, tick borne, inactivated, whole virus)is broader thanDE222 (Encepur)Per the Immunizations DAK
XM8MP6 (Encephalitis, tick borne, inactivated, whole virus)is broader thanDE223 (TBE-Moscow)Per the Immunizations DAK
XM8MP6 (Encephalitis, tick borne, inactivated, whole virus)is broader thanDE224 (EnceVir)Per the Immunizations DAK
XM8BU8 (Typhoid vaccines)is broader thanDE226 (Typbar-TCV)Per the Immunizations DAK
XM3SF6 (Typhoid, purified polysaccharide antigen vaccines)is broader thanDE227 (ViPS)Per the Immunizations DAK
XM33K4 (Typhoid, oral, live attenuated vaccines)is broader thanDE228 (Ty21a)Per the Immunizations DAK
XM3Z26 (Cholera, inactivated, whole cell vaccines)is equivalent toDE230 (WC vaccine)
XM29K4 (Cholera vaccines)is broader thanDE231 (WC-rBS vaccine)Per the Immunizations DAK
XM2280 (Meningococcus A, purified polysaccharides antigen conjugated vaccines)is equivalent toDE233 (MenA conjugate vaccine (5µg))
XM18Y8 (Meningococcus C, purified polysaccharides antigen conjugated vaccines)is equivalent toDE234 (Monovalent MenC conjugate)
XM2EH7 (Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated vaccines)is equivalent toDE235 (Quadrivalent conjugate)
XM92B2 (Meningococcal monovalent purified polysaccharides antigen vaccines)is narrower thanDE252 (Polysaccharide vaccine)
XM6LL6 (Hepatitis vaccines)is broader thanDE238 (Live attenuated hepatitis A vaccine)Per the Immunizations DAK
XM2A12 (Hepatitis A, inactivated, whole virus)is equivalent toDE239 (Inactivated hepatitis A vaccine)
XM9V38 (Hepatitis B, purified antigen)is related toDE255 (Hepatitis B monovalent vaccine)

Group 7 Mapping from IMMZ.D CodeSystem for Data Elements to Logical Observation Identifiers, Names and Codes (LOINC)

Source CodeRelationshipTarget CodeComment
DE19 (Vaccine type)is equivalent to39236-5 (Vaccine code (CPT) CPHS)
DE20 (Date and time of vaccination)is equivalent to30952-6 (Date and time of vaccination)
DE201 (Contact date)is equivalent to21975-8 (Date last contact)
DE202 (ANC contact number)is broader than75612-2 (Number of visits to this healthcare entity in the last 12 months)Per the Immunizations DAK
DE162 (Currently pregnant)is equivalent to82810-3 (Pregnancy status)
DE163 (Immunocompromised)is related to96381-9 (Immune status)
DE200 (Severely immunocompromised)is related to96381-9 (Immune status)
DE165 (Severely immunosuppressed)is related to96381-9 (Immune status)
DE187 (Immunodeficiency syndromes)is narrower than82757-6 (Immunodeficiency)
DE168 (Symptomatic HIV infection)is narrower than47244-9 (Symptom, diagnosis, or opportunistic infection related to HIV treatment)
DE170 (Receiving blood products)is narrower thanLL3859-7 (Blood products)
DE191 (Breastfeeding)is narrower than63895-7 (Breastfeeding status)
DE22 (Administrative area)is equivalent to72060-7 (Where was vaccine received)
DE23 (Vaccine manufacturer)is equivalent to30957-5 (Manufacturer name [Identifier] Vaccine)
DE24 (Vaccine batch number)is equivalent to30959-1 (Lot number [Identifier] Vaccine)
DE26 (Expiration date)is narrower than74066-2 (Expiration date of Medication [AHRQ])
DE34 (Dose quantity)is equivalent to82745-1 (Doses of vaccine given [#] --pre symptom onset)
DE93 (Reaction date)is equivalent to30953-4 (Date and time of onset of vaccination adverse event)
DE186 (Recommended follow-up date)is narrower than39289-4 (Follow-up (referred to) provider /specialist, appointment date CPHS)
DE204 (HIV status)is equivalent to55277-8 (HIV status)
DE205 (HIV-positive)is equivalent to45683-0 (HIV infection [Minimum Data Set])
DE208 (Preterm birth)is equivalent to76517-2 (Premature infant)
DE209 (Immunocompromised)is related to96381-9 (Immune status)
DE244 (IGRA)is narrower than27415-9 (Interferon gamma [Mass/volume] in Serum or Plasma)
DE245 (TST)is equivalent to39263-9 (Tuberculin screen test status CPHS)
DE247 (Positive)is related to45241-7 (Tuberculosis status)
DE211 (Birth weight in grams)is equivalent to8339-4 (Birth weight Measured)

Group 8 Mapping from Logical Observation Identifiers, Names and Codes (LOINC) to IMMZ.D CodeSystem for Data Elements

Source CodeRelationshipTarget CodeComment
39236-5 (Vaccine code (CPT) CPHS)is equivalent toDE19 (Vaccine type)
30952-6 (Date and time of vaccination)is equivalent toDE20 (Date and time of vaccination)
21975-8 (Date last contact)is equivalent toDE201 (Contact date)
75612-2 (Number of visits to this healthcare entity in the last 12 months)is narrower thanDE202 (ANC contact number)
82810-3 (Pregnancy status)is equivalent toDE162 (Currently pregnant)
96381-9 (Immune status)is related toDE163 (Immunocompromised)
96381-9 (Immune status)is related toDE200 (Severely immunocompromised)
96381-9 (Immune status)is related toDE165 (Severely immunosuppressed)
82757-6 (Immunodeficiency)is broader thanDE187 (Immunodeficiency syndromes)Per the Immunizations DAK
47244-9 (Symptom, diagnosis, or opportunistic infection related to HIV treatment)is broader thanDE168 (Symptomatic HIV infection)Per the Immunizations DAK
LL3859-7 (Blood products)is broader thanDE170 (Receiving blood products)Per the Immunizations DAK
63895-7 (Breastfeeding status)is broader thanDE191 (Breastfeeding)Per the Immunizations DAK
72060-7 (Where was vaccine received)is equivalent toDE22 (Administrative area)
30957-5 (Manufacturer name [Identifier] Vaccine)is equivalent toDE23 (Vaccine manufacturer)
30959-1 (Lot number [Identifier] Vaccine)is equivalent toDE24 (Vaccine batch number)
74066-2 (Expiration date of Medication [AHRQ])is broader thanDE26 (Expiration date)Per the Immunizations DAK
82745-1 (Doses of vaccine given [#] --pre symptom onset)is equivalent toDE34 (Dose quantity)
30953-4 (Date and time of onset of vaccination adverse event)is equivalent toDE93 (Reaction date)
39289-4 (Follow-up (referred to) provider /specialist, appointment date CPHS)is broader thanDE186 (Recommended follow-up date)Per the Immunizations DAK
55277-8 (HIV status)is equivalent toDE204 (HIV status)
45683-0 (HIV infection [Minimum Data Set])is equivalent toDE205 (HIV-positive)
76517-2 (Premature infant)is equivalent toDE208 (Preterm birth)
96381-9 (Immune status)is related toDE209 (Immunocompromised)
27415-9 (Interferon gamma [Mass/volume] in Serum or Plasma)is broader thanDE244 (IGRA)Per the Immunizations DAK
39263-9 (Tuberculin screen test status CPHS)is equivalent toDE245 (TST)
45241-7 (Tuberculosis status)is related toDE247 (Positive)
8339-4 (Birth weight Measured)is equivalent toDE211 (Birth weight in grams)

Group 9 Mapping from IMMZ.D CodeSystem for Data Elements to SNOMED CT (all versions)

Source CodeRelationshipTarget CodeComment
DE19 (Vaccine type)is broader than787859002 (Vaccine product)Per the Immunizations DAK
DE201 (Contact date)is related to406543005 (Date of visit)
DE202 (ANC contact number)is equivalent to3401000175105 (Total number of prenatal care visits)
DE158 (Due)is related to722187008 (Under immunized)
DE162 (Currently pregnant)is equivalent to77386006 (Pregnancy)
DE163 (Immunocompromised)is equivalent to370388006 (Patient immunocompromised)
DE200 (Severely immunocompromised)is narrower than370388006 (Patient immunocompromised)
DE164 (Exposed to immunosuppressive treatment)is narrower than86553008 (Immunosuppressive therapy)
DE165 (Severely immunosuppressed)is equivalent to370388006 (Patient immunocompromised)
DE187 (Immunodeficiency syndromes)is equivalent to234532001 (Immunodeficiency disorder)
DE166 (History of anaphylactic reactions)is equivalent to10839421000119100
DE167 (Severe allergic reactions)is narrower than419076005 (Allergic reaction)
DE168 (Symptomatic HIV infection)is equivalent to86406008 (Human immunodeficiency virus infection)
DE170 (Receiving blood products)is equivalent to116859006 (Transfusion of blood product)
DE188 (Severe acute illness)is narrower than39104002 (Illness)
DE190 (TB disease)is narrower than56717001 (Tuberculosis)
DE191 (Breastfeeding)is equivalent to169750002 (Mother currently breast-feeding)
DE192 (Spina bifida)is equivalent to67531005 (Spina bifida)
DE193 (Bladder exstrophy)is equivalent to204997000 (Exstrophy of urinary bladder NOS)
DE194 (Acute gastroenteritis)is narrower than69776003 (Acute gastroenteritis)
DE195 (Moderate to severe fever)is narrower than386661006 (Fever)
DE4 (Not done)is equivalent to385660001 (Not done)
DE9 (Client objection)is equivalent to591000119102 (Vaccine declined by patient)
DE13 (Immunocompromised)is equivalent to370388006 (Patient immunocompromised)
DE14 (Chronic illness or condition)is narrower than39104002 (Illness)
DE15 (Acute illness)is narrower than39104002 (Illness)
DE127 (Typhoid)is equivalent to4834000 (Typhoid fever)
DE128 (Influenza)is equivalent to6142004 (Influenza)
DE129 (Measles)is equivalent to14189004 (Measles)
DE133 (Pertussis)is equivalent to27836007 (Pertussis)
DE135 (Mumps)is equivalent to36989005 (Mumps)
DE136 (Varicella)is equivalent to38907003 (Varicella)
DE137 (Viral hepatitis A)is equivalent to40468003 (Viral hepatitis, type A)
DE139 (Tuberculosis)is equivalent to56717001 (Tuberculosis)
DE140 (Viral hepatitis B)is equivalent to66071002 (Type B viral hepatitis)
DE141 (Haemophilus influenzae type b)is equivalent to70036007 (Haemophilus influenzae pneumonia)
DE142 (Tetanus)is equivalent to76902006 (Tetanus)
DE143 (Rotavirus)is equivalent to186150001 (Enteritis caused by Rotavirus)
DE144 (Human papillomavirus)is equivalent to240532009 (Human papilloma virus infection)
DE175 (Japanese encephalitis)is equivalent to52947006 (Japanese encephalitis virus disease)
DE146 (Poliomyelitis)is equivalent to398102009 (Acute poliomyelitis)
DE176 (Diphtheria)is equivalent to397428000 (Diphtheria)
DE177 (Pneumococcal disease)is equivalent to16814004 (Pneumococcal infectious disease)
DE178 (Rubella)is equivalent to36653000 (Rubella)
DE179 (Dengue)is broader than20927009 (Dengue hemorrhagic fever)Per the Immunizations DAK
DE180 (Rabies)is equivalent to14168008 (Rabies)
DE181 (Meningococcal)is equivalent to7180009 (Meningitis)
DE182 (Cholera)is equivalent to63650001 (Cholera)
DE183 (Tick-borne encephalitis)is equivalent to712986001 (Encephalitis caused by tick-borne encephalitis virus)
DE184 (Yellow fever)is equivalent to16541001 (Yellow fever)
DE148 (COVID-19)is equivalent to840539006 (COVID-19)
DE92 (Reaction reported)is narrower than418799008 (Finding reported by subject or history provider)
DE108 (Death)is equivalent to399166001 (Fatal)
DE109 (Life threatening)is equivalent to442452003 (Life threatening severity)
DE110 (Disability)is equivalent to21134002 (Disability)
DE111 (Hospitalization)is equivalent to32485007 (Hospital admission)
DE112 (Congenital anomaly)is narrower than276654001 (Congenital malformation)
DE115 (Reaction outcome)is broader than293104008 (Vaccine adverse reaction)Per the Immunizations DAK
DE185 (Date/time of follow-up appointment)is narrower than185353001 (Appointment date)
DE186 (Recommended follow-up date)is narrower than410671006 (Date)
DE204 (HIV status)is equivalent to278977008 (HIV status)
DE205 (HIV-positive)is equivalent to165816005 (HIV detected)
DE206 (HIV-negative)is equivalent to165815009 (HIV not detected)
DE207 (Unknown)is narrower than261665006 (Unknown)
DE208 (Preterm birth)is equivalent to395507008 (Premature infant)
DE209 (Immunocompromised)is equivalent to370388006 (Patient immunocompromised)
DE244 (IGRA)is equivalent to68311008 (Interferon assay)
DE245 (TST)is equivalent to28163009 (Skin test for tuberculosis, Tine test)
DE247 (Positive)is narrower than10828004 (Positive)
DE248 (Negative)is narrower than260385009 (Negative)
DE213 (IPV)is equivalent to871740006 (Inactivated whole Human poliovirus antigen only vaccine product)

Group 10 Mapping from SNOMED CT (all versions) to IMMZ.D CodeSystem for Data Elements

Source CodeRelationshipTarget CodeComment
787859002 (Vaccine product)is narrower thanDE19 (Vaccine type)
406543005 (Date of visit)is related toDE201 (Contact date)
3401000175105 (Total number of prenatal care visits)is equivalent toDE202 (ANC contact number)
722187008 (Under immunized)is related toDE158 (Due)
77386006 (Pregnancy)is equivalent toDE162 (Currently pregnant)
370388006 (Patient immunocompromised)is equivalent toDE163 (Immunocompromised)
370388006 (Patient immunocompromised)is broader thanDE200 (Severely immunocompromised)Per the Immunizations DAK
86553008 (Immunosuppressive therapy)is broader thanDE164 (Exposed to immunosuppressive treatment)Per the Immunizations DAK
370388006 (Patient immunocompromised)is equivalent toDE165 (Severely immunosuppressed)
234532001 (Immunodeficiency disorder)is equivalent toDE187 (Immunodeficiency syndromes)
10839421000119100is equivalent toDE166 (History of anaphylactic reactions)
419076005 (Allergic reaction)is broader thanDE167 (Severe allergic reactions)Per the Immunizations DAK
86406008 (Human immunodeficiency virus infection)is equivalent toDE168 (Symptomatic HIV infection)
116859006 (Transfusion of blood product)is equivalent toDE170 (Receiving blood products)
39104002 (Illness)is broader thanDE188 (Severe acute illness)Per the Immunizations DAK
56717001 (Tuberculosis)is broader thanDE190 (TB disease)Per the Immunizations DAK
169750002 (Mother currently breast-feeding)is equivalent toDE191 (Breastfeeding)
67531005 (Spina bifida)is equivalent toDE192 (Spina bifida)
204997000 (Exstrophy of urinary bladder NOS)is equivalent toDE193 (Bladder exstrophy)
69776003 (Acute gastroenteritis)is broader thanDE194 (Acute gastroenteritis)Per the Immunizations DAK
386661006 (Fever)is broader thanDE195 (Moderate to severe fever)Per the Immunizations DAK
385660001 (Not done)is equivalent toDE4 (Not done)
591000119102 (Vaccine declined by patient)is equivalent toDE9 (Client objection)
370388006 (Patient immunocompromised)is equivalent toDE13 (Immunocompromised)
39104002 (Illness)is broader thanDE14 (Chronic illness or condition)Per the Immunizations DAK
39104002 (Illness)is broader thanDE15 (Acute illness)Per the Immunizations DAK
4834000 (Typhoid fever)is equivalent toDE127 (Typhoid)
6142004 (Influenza)is equivalent toDE128 (Influenza)
14189004 (Measles)is equivalent toDE129 (Measles)
27836007 (Pertussis)is equivalent toDE133 (Pertussis)
36989005 (Mumps)is equivalent toDE135 (Mumps)
38907003 (Varicella)is equivalent toDE136 (Varicella)
40468003 (Viral hepatitis, type A)is equivalent toDE137 (Viral hepatitis A)
56717001 (Tuberculosis)is equivalent toDE139 (Tuberculosis)
66071002 (Type B viral hepatitis)is equivalent toDE140 (Viral hepatitis B)
70036007 (Haemophilus influenzae pneumonia)is equivalent toDE141 (Haemophilus influenzae type b)
76902006 (Tetanus)is equivalent toDE142 (Tetanus)
186150001 (Enteritis caused by Rotavirus)is equivalent toDE143 (Rotavirus)
240532009 (Human papilloma virus infection)is equivalent toDE144 (Human papillomavirus)
52947006 (Japanese encephalitis virus disease)is equivalent toDE175 (Japanese encephalitis)
398102009 (Acute poliomyelitis)is equivalent toDE146 (Poliomyelitis)
397428000 (Diphtheria)is equivalent toDE176 (Diphtheria)
16814004 (Pneumococcal infectious disease)is equivalent toDE177 (Pneumococcal disease)
36653000 (Rubella)is equivalent toDE178 (Rubella)
20927009 (Dengue hemorrhagic fever)is narrower thanDE179 (Dengue)
14168008 (Rabies)is equivalent toDE180 (Rabies)
7180009 (Meningitis)is equivalent toDE181 (Meningococcal)
63650001 (Cholera)is equivalent toDE182 (Cholera)
712986001 (Encephalitis caused by tick-borne encephalitis virus)is equivalent toDE183 (Tick-borne encephalitis)
16541001 (Yellow fever)is equivalent toDE184 (Yellow fever)
840539006 (COVID-19)is equivalent toDE148 (COVID-19)
418799008 (Finding reported by subject or history provider)is broader thanDE92 (Reaction reported)Per the Immunizations DAK
399166001 (Fatal)is equivalent toDE108 (Death)
442452003 (Life threatening severity)is equivalent toDE109 (Life threatening)
21134002 (Disability)is equivalent toDE110 (Disability)
32485007 (Hospital admission)is equivalent toDE111 (Hospitalization)
276654001 (Congenital malformation)is broader thanDE112 (Congenital anomaly)Per the Immunizations DAK
293104008 (Vaccine adverse reaction)is narrower thanDE115 (Reaction outcome)
185353001 (Appointment date)is broader thanDE185 (Date/time of follow-up appointment)Per the Immunizations DAK
410671006 (Date)is broader thanDE186 (Recommended follow-up date)Per the Immunizations DAK
278977008 (HIV status)is equivalent toDE204 (HIV status)
165816005 (HIV detected)is equivalent toDE205 (HIV-positive)
165815009 (HIV not detected)is equivalent toDE206 (HIV-negative)
261665006 (Unknown)is broader thanDE207 (Unknown)Per the Immunizations DAK
395507008 (Premature infant)is equivalent toDE208 (Preterm birth)
370388006 (Patient immunocompromised)is equivalent toDE209 (Immunocompromised)
68311008 (Interferon assay)is equivalent toDE244 (IGRA)
28163009 (Skin test for tuberculosis, Tine test)is equivalent toDE245 (TST)
10828004 (Positive)is broader thanDE247 (Positive)Per the Immunizations DAK
260385009 (Negative)is broader thanDE248 (Negative)Per the Immunizations DAK
871740006 (Inactivated whole Human poliovirus antigen only vaccine product)is equivalent toDE213 (IPV)